Literature DB >> 8450836

Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.

U Quast1, K M Bray, H Andres, P W Manley, Y Baumlin, J Dosogne.   

Abstract

P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N"-3-pyridylguanidine], an analogue of the K+ channel opener pinacidil, was shown to be a K+ channel opener in rat aorta, based on (i) its ability to stimulate 86Rb+ efflux, (ii) its ability to relax contractions in response to noradrenaline under normal conditions (5 mM KCl) but not under depolarized conditions (55 mM KCl), and (iii) the sensitivity of these effects to inhibition by the sulfonylurea glibenclamide. In these assays, P1075 was approximately 20 times more potent than cromakalim. Using a tritiated derivative, [3H] P1075, specific binding could not be detected in microsomal preparations from various tissues. However, in rat aortic strips specific binding of [3H]P1075 has been observed and was reduced by lowering the temperature or by decreasing intracellular ATP levels via metabolic inhibition. Specific [3H]P1075 binding was influenced neither by depolarization (55 mM KCl) nor by lowering the pH from 7.4 to 6.0. Binding was inhibited by representatives from all major families of K+ channel openers, with potencies that correlated well with the potencies obtained in 86Rb+ efflux and relaxation studies. However, stimulation of 86Rb+ efflux occurred at 40 times higher concentrations than did binding (and vasorelaxation). Of the various inhibitors of the K+ channel openers tested, only the sulfonylureas inhibited [3H] P1075 binding with the same rank order of potencies as that required for inhibition of P1075-induced 86Rb+ efflux, although at higher concentrations. The results show that binding of [3H] P1075 is independent of membrane potential but decreases concomitantly with the intracellular ATP level. The excellent correlation between the potencies of the openers and sulfonylurea blockers in binding assays and functional studies suggests that the 'drug receptor' labeled by [3H]P1075 in rat isolated aorta is of functional relevance. However, the fact that binding of the openers occurred at concentrations considerably lower than those required for K+ channel opening and that binding of the sulfonylureas was only reflected at concentrations higher than those needed to block the channel requires complex models to link binding and effect, possibly involving two agonist binding sites coupled by negative cooperativity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450836

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

Authors:  P W Manley; C Löffler-Walz; U Russ; A Hambrock; T Moenius; U Quast
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.

Authors:  F Metzger; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

Review 5.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.

Authors:  U Russ; U Rauch; U Quast
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

7.  Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.

Authors:  M Meyer; F Chudziak; C Schwanstecher; M Schwanstecher; U Panten
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  KATP channel openers of the benzopyran type reach their binding site via the cytosol.

Authors:  D Stephan; E Salamon; H Weber; U Russ; H Lemoine; U Quast
Journal:  Br J Pharmacol       Date:  2006-08-14       Impact factor: 8.739

9.  Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

Authors:  Annette Hambrock; Cornelia Löffler-Walz; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.

Authors:  C Linde; U Quast
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.